Acknowledgement
We are thankful to Indian Council of Medical Research (ICMR), New Delhi for providing the Senior Research fellowship.
References
- Yuan Y, You Y, Huang D, Cui J, Wang Y, Wang Q, et al. Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China. J Transl Med 2009;7:79. https://doi.org/10.1186/1479-5876-7-79
- Bitarafan F, Seyedena SY, Mahmoudi M, Garshasbi M. Identification of novel variants in Iranian consanguineous pedigrees with nonsyndromic hearing loss by next-generation sequencing. J Clin Lab Anal 2020;34:e23544. https://doi.org/10.1002/jcla.23544
- Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med 2017;377:2465-2473. https://doi.org/10.1056/NEJMra1616601
- Korver AM, Smith RJ, Van Camp G, Schleiss MR, Bitner-Glindzicz MA, Lustig LR, et al. Congenital hearing loss. Nat Rev Dis Primers 2017;3:16094. https://doi.org/10.1038/nrdp.2016.94
- Schrijver I. Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J Mol Diagn 2004;6:275-284. https://doi.org/10.1016/S1525-1578(10)60522-3
- Sindura KP, Banerjee M. An immunological perspective to non-syndromic sensorineural hearing loss. Front Immunol 2019;10:2848. https://doi.org/10.3389/fimmu.2019.02848
- Bozanic Urbancic N, Battelino S, Tesovnik T, Trebusak Podkrajsek K. The importance of early genetic diagnostics of hearing loss in children. Medicina (Kaunas) 2020;56:471. https://doi.org/10.3390/medicina56090471
- Cabanillas R, Dineiro M, Cifuentes GA, Castillo D, Pruneda PC, Alvarez R, et al. Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients. BMC Med Genomics 2018;11:58. https://doi.org/10.1186/s12920-018-0375-5
- Shaffer JR, Feingold E, Marazita ML. Genome-wide association studies: prospects and challenges for oral health. J Dent Res 2012;91:637-641. https://doi.org/10.1177/0022034512446968
- Bush WS, Moore JH. Chapter 11: Genome-wide association studies. PLoS Comput Biol 2012;8:e1002822. https://doi.org/10.1371/journal.pcbi.1002822
- Schenone M, Dancik V, Wagner BK, Clemons PA. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 2013;9:232-240. https://doi.org/10.1038/nchembio.1199
- Rai A, Shinde P, Jalan S. Network spectra for drug-target identification in complex diseases: new guns against old foes. Appl Netw Sci 2018;3:51. https://doi.org/10.1007/s41109-018-0107-y
- Udhaya Kumar S, Thirumal Kumar D, Bithia R, Sankar S, Magesh R, Sidenna M, et al. Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach. Front Genet 2020;11:734. https://doi.org/10.3389/fgene.2020.00734
- Zhu HM, Fei Q, Qian LX, Liu BL, He X, Yin L. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis. Oncol Lett 2019;17:4683-4694.
- Chen L, Chu C, Lu J, Kong X, Huang T, Cai YD. Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system. PLoS One 2015;10:e0126492. https://doi.org/10.1371/journal.pone.0126492
- Karimizadeh E, Sharifi-Zarchi A, Nikaein H, Salehi S, Salamatian B, Elmi N, et al. Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis. BMC Med Genomics 2019;12:199. https://doi.org/10.1186/s12920-019-0632-2
- Tomkins JE, Manzoni C. Advances in protein-protein interaction network analysis for Parkinson's disease. Neurobiol Dis 2021;155:105395. https://doi.org/10.1016/j.nbd.2021.105395
- Fan R, Dong L, Li P, Wang X, Chen X. Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma. PLoS One 2021;16:e0251962. https://doi.org/10.1371/journal.pone.0251962
- Srivastava N, Mishra BN, Srivastava P. Protein network analysis to prioritize key genes and pathway for stress-mediated neurodegeneration. Open Bioinformatics J 2018;11:240-251. https://doi.org/10.2174/1875036201811010240
- Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011;39:6845-6853. https://doi.org/10.1093/nar/gkr330
- Mahmoodian Sani MR, Hashemzadeh-Chaleshtori M, Saidijam M, Jami MS, Ghasemi-Dehkordi P. MicroRNA-183 family in inner ear: hair cell development and deafness. J Audiol Otol 2016;20:131-138. https://doi.org/10.7874/jao.2016.20.3.131
- Chadly DM, Best J, Ran C, Bruska M, Wozniak W, Kempisty B, et al. Developmental profiling of microRNAs in the human embryonic inner ear. PLoS One 2018;13:e0191452. https://doi.org/10.1371/journal.pone.0191452
- Solda G, Robusto M, Primignani P, Castorina P, Benzoni E, Cesarani A, et al. A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 2012;21:577-585. https://doi.org/10.1093/hmg/ddr493
- Hildebrand MS, Witmer PD, Xu S, Newton SS, Kahrizi K, Najmabadi H, et al. miRNA mutations are not a common cause of deafness. Am J Med Genet A 2010;152:646-652.
- Matsuda K. PCR-based detection methods for single-nucleotide polymorphism or mutation: real-time PCR and its substantial contribution toward technological refinement. Adv Clin Chem 2017;80:45-72. https://doi.org/10.1016/bs.acc.2016.11.002
- Shastry BS. SNPs in disease gene mapping, medicinal drug development and evolution. J Hum Genet 2007;52:871-880. https://doi.org/10.1007/s10038-007-0200-z
- Das SS, Chakravorty N. Identification of deleterious SNPs and their effects on BCL11A, the master regulator of fetal hemoglobin expression. Genomics 2020;112:397-403. https://doi.org/10.1016/j.ygeno.2019.03.002
- Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 2012;40:W452-W457. https://doi.org/10.1093/nar/gks539
- Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, et al. PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 2014;10:e1003440. https://doi.org/10.1371/journal.pcbi.1003440
- Bendl J, Musil M, Stourac J, Zendulka J, Damborsky J, Brezovsky J. PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions. PLoS Comput Biol 2016;12:e1004962. https://doi.org/10.1371/journal.pcbi.1004962
- Kiernan AE. Notch signaling during cell fate determination in the inner ear. Semin Cell Dev Biol 2013;24:470-479. https://doi.org/10.1016/j.semcdb.2013.04.002
- Munnamalai V, Fekete DM. Wnt signaling during cochlear development. Semin Cell Dev Biol 2013;24:480-489. https://doi.org/10.1016/j.semcdb.2013.03.008
- Riccomagno MM, Takada S, Epstein DJ. Wnt-dependent regulation of inner ear morphogenesis is balanced by the opposing and supporting roles of Shh. Genes Dev 2005;19:1612-1623. https://doi.org/10.1101/gad.1303905
- Zhao HB, Kikuchi T, Ngezahayo A, White TW. Gap junctions and cochlear homeostasis. J Membr Biol 2006;209:177-186. https://doi.org/10.1007/s00232-005-0832-x
- Wang B, Hu B, Yang S. Cell junction proteins within the cochlea: a review of recent research. J Otol 2015;10:131-135. https://doi.org/10.1016/j.joto.2016.01.003
- Kitajiri S, Katsuno T. Tricellular tight junctions in the inner ear. Biomed Res Int 2016;2016:6137541. https://doi.org/10.1155/2016/6137541
- Nayak G, Lee SI, Yousaf R, Edelmann SE, Trincot C, Van Itallie CM, et al. Tricellulin deficiency affects tight junction architecture and cochlear hair cells. J Clin Invest 2013;123:4036-4049. https://doi.org/10.1172/JCI69031
- Wilson T, Omelchenko I, Foster S, Zhang Y, Shi X, Nuttall AL. JAK2/STAT3 inhibition attenuates noise-induced hearing loss. PLoS One 2014;9:e108276. https://doi.org/10.1371/journal.pone.0108276
- Mittal R, Liu G, Polineni SP, Bencie N, Yan D, Liu XZ. Role of microRNAs in inner ear development and hearing loss. Gene 2019;686:49-55. https://doi.org/10.1016/j.gene.2018.10.075
- Trune DR. Ion homeostasis in the ear: mechanisms, maladies, and management. Curr Opin Otolaryngol Head Neck Surg 2010;18:413-419. https://doi.org/10.1097/MOO.0b013e32833d9597
- Sohmer H. Pathophysiological mechanisms of hearing loss. J Basic Clin Physiol Pharmacol 1997;8:113-125. https://doi.org/10.1515/JBCPP.1997.8.3.113
- Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, et al. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One 2012;7:e51056. https://doi.org/10.1371/journal.pone.0051056
- Ueno K, Hirata H, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, et al. microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer 2013;108:1659-1667. https://doi.org/10.1038/bjc.2013.125
- Zhou J, Zhang C, Zhou B, Jiang D. miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-beta/ Smad4 signaling pathway. Int J Mol Med 2019;43:1734-1746.
- Lewis MA, Di Domenico F, Ingham NJ, Prosser HM, Steel KP. Hearing impairment due to Mir183/96/182 mutations suggests both loss and gain of function effects. Dis Model Mech 2020;14:dmm047225.
- Du X, Li Q, Yang L, Liu L, Cao Q, Li Q. SMAD4 activates Wnt signaling pathway to inhibit granulosa cell apoptosis. Cell Death Dis 2020;11:373. https://doi.org/10.1038/s41419-020-2578-x
- Gallione C, Aylsworth AS, Beis J, Berk T, Bernhardt B, Clark RD, et al. Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. Am J Med Genet A 2010;152A:333-339. https://doi.org/10.1002/ajmg.a.33206
- Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004;363:852-859. https://doi.org/10.1016/S0140-6736(04)15732-2
- Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius MM, Loff S, et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 2007;44:702-709. https://doi.org/10.1136/jmg.2007.052506
- Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 2004;41:484-491. https://doi.org/10.1136/jmg.2004.018598
- Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin JP, et al. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 2005;11:2606-2611. https://doi.org/10.1158/1078-0432.ccr-04-1458
- Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol 2001;2:REVIEWS3010.
- Kuang C, Chen Y. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Oncogene 2004;23:1021-1029. https://doi.org/10.1038/sj.onc.1207219